Prosthetic Heart Valves - Global Trends, Estimates and Forecasts, 2012-2018

DUBLIN, Dec. 10, 2014 /PRNewswire/ --Research and Markets

( has announced the addition of the "Prosthetic Heart Valves - Global Trends, Estimates and Forecasts, 2012-2018" report to their offering.

The Cardiac Prosthetic Heart Valves market value is expected to reach US$2.9 billion by 2016, primarily supported by the product types - Mechanical Heart Valves, Transluminal Heart Valves and Tissue Heart Valves. Geographical analysis for Cardiac Prosthetic Heart Valves market shows that the highest Compounded Annual Growth Rate (CAGR) of 10.8% is anticipated from Asia-Pacific region during the analysis period 2012-2018. Globally, Mechanical Heart Valves account for approximately 48% of the market share for 2018.

Healthcare Industry division has been witnessing a drastic change regarding the new innovation and technology which in terms are applied in improving from sector to sector since the past 3-5 years. Cardiovascular industry growth continues to increase with the presence of multiple technologies such as advanced material and software which is featured in most of the devices. International companies tends to innovate, develop new products and to enhance the existing features in cardiovascular devices.

The period considered for the prosthetic heart valves market analysis is 2012-2018. The region wise distribution of the market consists of North America (USA and Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Belgium and Rest of Europe), Asia-Pacific (Japan, China, India, New Zealand, South Korea, Australia and Rest of Asia-Pacific)), Latin America (Brazil, Argentina and Rest of Latin America) and Rest of World (South Africa, Middle East and Rest of Rest of World). The market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually.

More than 727 market players are identified in cardiovascular devices industry out of which 122 key companies that project improved market activities in the near future are profiled. The report consists of 143 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments.

Companies Mentioned:

  • 3M Healthcare
  • Abbott Vascular Devices
  • Abiomed
  • Accellent
  • Accutech, Llc
  • Advansource Biomaterials Corporation
  • Aerotel Medical Systems, Ltd.
  • Alere
  • All Pro Corporation
  • Ambu A/S
  • Angiodynamics
  • Aortech International, Plc.
  • Apc Cardiovascular, Ltd.
  • Aptus Endosystems
  • Arterial Remodeling Technologiesuscome Limited
  • Asahi Intecc Co., Ltd.
  • Asahi Kasei Corporation
  • Ash Access Technology
  • Asian Heart Institute
  • Atcor Medical Holdings Limited
  • Atricure
  • Atrium Medical Corporation
  • Baxter International Inc.
  • Becton, Dickinson & Co.
  • Beijing Anzhen Hospital
  • Berlin Heart Gmbh
  • Bioclinica
  • Bioheart
  • Biophan Technologies
  • Biosense Webster
  • Biosensors International Group, Ltd.
  • Biotelemetry
  • Bioteque Corporation
  • Biotronik Gmbh & Co. Kg.
  • Boston Scientific Corporation
  • C. R. Bard
  • Cambridge Heart
  • Cardiac Science Corporation
  • Cardiacassist
  • Cardica
  • Cardiocomm Solutions
  • Cardiorobotics
  • Cardiovascularsystems
  • Cardium Therapeutics
  • Cardiva Medical
  • Cathrx Ltd
  • Circulite
  • Compumed
  • Conmed Corporation
  • Cook Group Incorporated
  • Cordis Corporation
  • Covidien Plc
  • Cryolife Inc.
  • Deltex Medical Group Plc
  • Digirad Corporation
  • Dräger Medical Ag & Co. Kg
  • Edwards Lifesciences, Llc.
  • Endologix Incorporated
  • Esaote S.P.A
  • Fleming Medical Limited
  • Fluxion
  • Fudan University Zhongshan Hospital
  • Fukuda Denshi Co., Ltd.
  • Gamida Cell Ltd.
  • Ge Healthcare
  • Goodman Co., Ltd.
  • Greatbatch
  • Heartware Ltd.
  • Hospira
  • Indraprastha Apollo Hospital
  • Inspiremd Ltd.
  • Interface Biologics
  • Issys Sensing Systems
  • Itgi Medical Ltd.
  • Johnson & Johnson
  • Key Company
  • Koninklijkedsm N.V.
  • Lepu Medical
  • Levitronix, Llc
  • Lidco Group Plc
  • Lombard Medical Technologies Plc
  • Maquet Gmbh & Co. Kg
  • Medinol, Ltd.
  • Medrad
  • Medtronic
  • Meridian Health System
  • Merit Medical Systems
  • Microports Medical
  • Millar Instruments
  • Molecular Devices, Llc
  • Monebo Technologies
  • Mortara Instrument
  • Narayana Hrudayalaya
  • Nihon Kohden Corporation
  • Novadaq Technologies Inc.
  • Opto Circuits India Limited
  • Philips Medical Systems
  • Pulsion Medical Systems Se
  • Sahajanand Medical Technologies Pvt.,Ltd.
  • Scottcare Cardiovascular Solutions
  • Sichuan Jinjiang Electronic Science And Technology Co., Ltd
  • Siemens Medical Solutions Usa
  • Smith & Nephew Plc
  • Sonosite
  • Sophion Bioscience A/S
  • Sorin Group Usa
  • Spectranetics International B.V
  • St. Jude Medical
  • Stereotaxis
  • Sunshine Heart
  • Surgical Specialisties Corporation
  • Syncardia Systems
  • Teleflex
  • Terumo Cardiovascular Systems Corporation
  • Terumo Heart
  • Thermedics
  • Thoratec Corporation
  • Ttk Healthcare
  • Varian Medical Systems
  • Vascular Concepts
  • Vicor Technologies
  • Volcano Corporation

For more information visit

Media Contact: Laura Wood , +353-1-481-1716, [email protected]

To view the original version on PR Newswire, visit:

SOURCE Research and Markets

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.